Mexico The United States Trade Representative Office has been engaging with a number of countries, including Mexico, to address concerns related to IP protection and enforcement and market access barriers for pharmaceuticals and medical devices. Mexico remained on USTR’s Watch List in 2019 because there has not been a significant change…

Opinion BIO’s Greg Frank outlines the alarming growth of drug-resistant infections and the steps that need to be taken to combat this rapidly emerging global health threat.   Drug-resistant superbugs are evolving at a rapid pace. In fact, it is estimated that 700,000 people die from drug-resistant infections each year. Without…

China PharmaBoardroom sat down with more than 25 biotech CEOs in China in 2019. We analyzed the contents of the interviews and found the following recurring themes at the top of these executives’ minds.   “Patients” One recurring theme throughout the interviews was a stated commitment to patients. Many of these…

Artificial Intelligence Digital health deal values in biopharma jumped to USD 6.4 billion in 2019, largely thanks to software company Dassault Systemes Americas Corp.’s USD 5.9 billion acquisition of health tech company Medidata Solutions, according to analysis by S&P Global Market Intelligence. “Traditional investors in the digital health startup space have generally…

Artificial Intelligence With so many wild predictions being bandied around about AI’s potential to radically transform healthcare for the better, it is easy to lose sight of the fact that materialization of that dream will be far from easy. Indeed, the task a hand can seem quite formidable. Most pharma companies’ existing…

Artificial Intelligence As data and information proliferate at an exponential pace, many industries have turned to artificial intelligence to make sense of this information and deliver meaningful insights that can enhance performance. This is certainly the case for the healthcare sector, where the technology augurs nothing less than a paradigm shift towards…

Artificial Intelligence On the supply side, AI appears to herald the prospect of de-risking the drug discovery process and doing away with many of the traditional time-consuming approaches at a juncture when drug development had been becoming financially unsustainable and clinical research organisations (CROs) had been systematically failing to improve operational efficiency.…

Artificial Intelligence The AI in Life Sciences Market was valued at USD 902.1 million in 2019 by Mordor Intelligence and is projected to expand at an impressive 20 percent compound annual growth rate in the period 2020 to 2024. Yet despite the massive hype and enthusiasm around artificial intelligence’s propensity to positively…

Puerto Rico When life sciences companies decide to transfer the production of new drug to Puerto Rico, extend an existing production line, or simply sustain existing operations, they can count on the support of a vast network of service providers with unmatched expertise in quality and regulatory compliance, from premarket approval (PMA)…

Puerto Rico Going into a pharmacy has never been more convenient in the United States and its territories. People living near urban centres need not travel far to find a 24 hour-supermarket-style pharmacy. It is not only about acquiring medication, but about offering everything customers might need, from cheddar cheese to XL…

Puerto Rico In Puerto Rico, approximately 16 percent of the adult population has diabetes, one the highest prevalence in the world, compared to 10 percent in the general US population. As a result, diabetes represents a significant burden to the local healthcare system and population.   To tackle the rise of diabetes,…

China As patients and consumers grow more educated and proactive in managing their own health and wellbeing, new ventures are hoping to serve their needs in not just prophylactic but also preventative health. HiNounou is a nifty little start-up based in Shanghai seeking to redefine the health management app.   Health…